Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Eurofarma's Formoterol/Budesonide vs Foraseq and Alenia in Asthma
NCT01167010Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Apr 2011
- Primary completion
- Aug 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide + formoterol in asthma, sponsored by Eurofarma. Started Apr 2011; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01167010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167010.